Insider Ledger
Exelixis, Inc. (EXEL) insider buying and SEC filings
Exelixis, Inc. · CIK 939767
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Jan 1
- Former names
- EXELIXIS INC
Insider activity in the last 12 months
Bought
$1.2M
Insiders who bought
1
Sold (not marked 10b5-1)
$29.7M
Planned sales (10b5-1)
$6.9M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 10, 2026 | Planned (10b5-1) | Mary C Beckerle (Director) sold 9,812 shares at about $53.66 ($527K), marked as a 10b5-1 plan trade. Holdings down 38% to 16,079 shares. | SEC filing Filed Aug 12, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Jack L. Wyszomierski (Director) sold 3,925 shares at $50.55 ($198K), marked as a 10b5-1 plan trade. Holdings down 1% to 284,384 shares. | SEC filing Filed Jun 3, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Sue Gail Eckhardt (Director) sold 9,812 shares at about $50.14 ($492K), marked as a 10b5-1 plan trade. Holdings down 38% to 16,079 shares. | SEC filing Filed Jun 3, 2026 |
| May 26, 2026 | Sale | Dana Aftab (EVP, Research and Development) sold 43,451 shares at $50.35 ($2.2M). Holdings down 7% to 594,741 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 28, 2026 |
| May 20, 2026 | Sale | Patrick J. Haley (EVP, Commercial) sold 32,110 shares at about $49.81 ($1.6M). Holdings down 8% to 357,638 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 18, 2026 | Sale | Christopher J. Senner (CFO) sold 34,901 shares at about $50.00 ($1.7M). Holdings down 4% to 952,317 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 18, 2026 | Planned (10b5-1) | Brenda Hefti (SVP and General Counsel) sold 6,625 shares at about $50.21 ($333K), marked as a 10b5-1 plan trade. Holdings down 6% to 106,762 shares. | SEC filing Filed May 19, 2026 |
| May 7, 2026 | Sale | Mary C Beckerle (Director) sold 7,712 shares at $48.45 ($374K). Holdings down 31% to 17,524 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 8, 2026 |
| May 7, 2026 | Sale | George Poste (Director) sold 60,000 shares at about $45.71 ($2.7M). Holdings down 34% to 118,832 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 8, 2026 |
| Feb 24, 2026 | Sale | Dana Aftab (EVP, Research and Development) sold 47,918 shares at $44.50 ($2.1M). Holdings down 7% to 616,106 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 19, 2026 | Sale | Dana Aftab (EVP, Research and Development) sold 29,873 shares at $44.35 ($1.3M). Holdings down 4% to 664,024 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Jack L. Wyszomierski (Director) sold 99,574 shares at about $44.01 ($4.4M), marked as a 10b5-1 plan trade. Holdings down 26% to 279,942 shares. | SEC filing Filed Feb 20, 2026 |
| Feb 17, 2026 | Sale | Patrick J. Haley (EVP, Commercial) sold 67,814 shares at about $43.52 ($3.0M). Holdings down 15% to 381,908 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Brenda Hefti (SVP and General Counsel) sold 18,669 shares at about $44.01 ($822K), marked as a 10b5-1 plan trade. Holdings down 16% to 96,512 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 13–17, 2026 | Sale | Christopher J. Senner (CFO) sold 64,895 shares between Feb 13 and Feb 17 at about $43.32 ($2.8M). Holdings down 6% to 976,092 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Planned (10b5-1) | Sue Gail Eckhardt (Director) sold 3,856 shares at about $43.79 ($169K), marked as a 10b5-1 plan trade. Holdings down 18% to 17,524 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Sale | Bob Oliver (Director) sold 30,250 shares at about $43.81 ($1.3M). Holdings down 59% to 21,120 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Nov 25, 2025 | Purchase (code P) | David Edward Johnson (Director) bought 27,532 shares indirectly at $43.12 ($1.2M), reported as a purchase (code P). Indirect holdings up 2% to 1,553,262 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 26, 2025 |
| Nov 20–21, 2025 | Sale | Patrick J. Haley (EVP, Commercial) sold 72,230 shares directly and indirectly (by spouse) between Nov 20, 2025 and Nov 21, 2025 at about $42.18 ($3.0M). Direct holdings down 9% to 374,029 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 12, 2025 | Sale | Stelios Papadopoulos (Director) sold 100,000 shares at about $43.55 ($4.4M). Holdings down 8% to 1,189,228 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
| Nov 11, 2025 | Sale | Dana Aftab (EVP, Research and Development) sold 48,383 shares at about $42.50 ($2.1M). Holdings down 7% to 664,778 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
| Nov 11, 2025 | Sale | Mary C Beckerle (Director) sold 24,622 shares at about $41.93 ($1.0M). Holdings down 54% to 21,380 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
42 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 29, 2026, 4:09 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EXEL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.